C12N 2760/18564
By serial passage
Official title: by serial passage
C12N2760/18564 (By serial passage) appears on 5 US grants and 1 published applications in this corpus.
Search patents in C12N- Granted patents
- 5
- Published applications
- 1
- Assignees
- 4
- Inventors
- 12
- Latest grant
- 21 Apr 2015
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1985 | 1 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 1 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 1 | 0 |
| 2000 | 1 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 1 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 1 | 0 |
By publication year. Applications have been published since 2001.
Recent patents
- Live, attenuated respiratory syncytial virus21 Apr 2015US 9,011,876 B2Merck Sharp & Dohme Corp.
- Attenuated respiratory syncytial virus20 Jun 2000US 6,077,514 AThe Regents of the University of Michigan
- Mutant respiratory syncytial virus (RSV), vaccines containing same and methods of use3 Aug 1999US 5,932,222 AAmerican Cyanamid Company
- Production of cell strains capable of propagating respiratory syncytial virus, compositions containing such virus and their use in diagnosis of respiratory syncytial virus infection10 Dec 1991US 5,071,758 ANational Research Development Corporation
- Production of viral antigens14 May 1985US 4,517,304 ANational Research Development Corporation
Most cited
By later US patents
- Production of viral antigens37US 4,517,304 ANational Research Development Corporation · 1985
- Production of cell strains capable of propagating respiratory syncytial virus, compositions containing such virus and their use in diagnosis of respiratory syncytial virus infection31US 5,071,758 ANational Research Development Corporation · 1991
- Live, attenuated respiratory syncytial virus6US 9,011,876 B2Merck Sharp & Dohme Corp. · 2015
- Attenuated respiratory syncytial virus4US 6,077,514 AThe Regents of the University of Michigan · 2000
- Mutant respiratory syncytial virus (RSV), vaccines containing same and methods of use3US 5,932,222 AAmerican Cyanamid Company · 1999